Solatorio, Josephine .

HRN: 17-02-50  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/09/2025
03/16/2025
IV
2.25g
Q6h
T/c Urosepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: